DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China
· Delayed Price · Currency is CNY 19.33
+0.58 (3.09%)
Apr 29, 2026, 2:15 PM CST
SHA:603233 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 27,519 | 27,502 | 25,861 | 23,931 | 20,780 | 16,759 | Upgrade
|
| Other Revenue | - | - | 635.56 | 599.94 | 467.67 | - | Upgrade
|
| Revenue | 27,519 | 27,502 | 26,497 | 24,531 | 21,248 | 16,759 | Upgrade
|
| Revenue Growth (YoY) | 3.07% | 3.79% | 8.01% | 15.45% | 26.78% | 14.92% | Upgrade
|
| Cost of Revenue | 18,001 | 18,064 | 17,422 | 15,795 | 13,226 | 10,385 | Upgrade
|
| Gross Profit | 9,519 | 9,438 | 9,074 | 8,736 | 8,022 | 6,374 | Upgrade
|
| Selling, General & Admin | 7,234 | 7,215 | 7,424 | 6,808 | 6,270 | 5,187 | Upgrade
|
| Research & Development | 42.09 | 41.27 | 51.68 | 80.93 | 74.38 | 44.61 | Upgrade
|
| Other Operating Expenses | 108.09 | 86.92 | 35.47 | 35.32 | 64.57 | 29.94 | Upgrade
|
| Operating Expenses | 7,384 | 7,343 | 7,527 | 6,940 | 6,432 | 5,273 | Upgrade
|
| Operating Income | 2,134 | 2,095 | 1,547 | 1,796 | 1,590 | 1,101 | Upgrade
|
| Interest Expense | -1.94 | - | -248.83 | -239.26 | -231.97 | -212.04 | Upgrade
|
| Interest & Investment Income | - | 0.33 | 82.23 | 91.75 | 68.89 | 77.7 | Upgrade
|
| Other Non Operating Income (Expenses) | -161.51 | -177.88 | -46.32 | -49.85 | -48.52 | -29.15 | Upgrade
|
| EBT Excluding Unusual Items | 1,971 | 1,918 | 1,335 | 1,599 | 1,379 | 937.76 | Upgrade
|
| Impairment of Goodwill | - | - | -38.6 | -6.21 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.45 | -1.52 | 10.61 | 4.38 | -18.71 | 34.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | 18.04 | 14.7 | 19.21 | 3.43 | 18.73 | 5.63 | Upgrade
|
| Asset Writedown | -76.46 | -81.37 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 13.89 | 27.05 | 36.36 | 65.94 | Upgrade
|
| Pretax Income | 1,907 | 1,849 | 1,340 | 1,628 | 1,415 | 1,044 | Upgrade
|
| Income Tax Expense | 502.24 | 490.53 | 359.73 | 397.12 | 335.62 | 239.52 | Upgrade
|
| Earnings From Continuing Operations | 1,405 | 1,359 | 979.94 | 1,231 | 1,079 | 804.39 | Upgrade
|
| Minority Interest in Earnings | -118.42 | -123.67 | -65.19 | -64.16 | -43.55 | -13.16 | Upgrade
|
| Net Income | 1,286 | 1,235 | 914.75 | 1,166 | 1,036 | 791.23 | Upgrade
|
| Net Income to Common | 1,286 | 1,235 | 914.75 | 1,166 | 1,036 | 791.23 | Upgrade
|
| Net Income Growth | 31.76% | 35.04% | -21.58% | 12.63% | 30.90% | -25.51% | Upgrade
|
| Shares Outstanding (Basic) | 1,140 | 1,144 | 1,129 | 1,133 | 1,138 | 1,130 | Upgrade
|
| Shares Outstanding (Diluted) | 1,140 | 1,144 | 1,129 | 1,133 | 1,138 | 1,130 | Upgrade
|
| Shares Change (YoY) | 0.71% | 1.28% | -0.28% | -0.50% | 0.69% | -0.24% | Upgrade
|
| EPS (Basic) | 1.13 | 1.08 | 0.81 | 1.03 | 0.91 | 0.70 | Upgrade
|
| EPS (Diluted) | 1.13 | 1.08 | 0.81 | 1.03 | 0.91 | 0.70 | Upgrade
|
| EPS Growth | 30.84% | 33.33% | -21.36% | 13.19% | 30.00% | -25.33% | Upgrade
|
| Free Cash Flow | 4,037 | 4,865 | 1,630 | 1,377 | 2,722 | 260.05 | Upgrade
|
| Free Cash Flow Per Share | 3.54 | 4.25 | 1.44 | 1.22 | 2.39 | 0.23 | Upgrade
|
| Dividend Per Share | - | - | 0.620 | 0.310 | 0.500 | 0.347 | Upgrade
|
| Dividend Growth | - | - | 100.00% | -38.00% | 43.97% | -24.99% | Upgrade
|
| Gross Margin | 34.59% | 34.32% | 34.25% | 35.61% | 37.76% | 38.03% | Upgrade
|
| Operating Margin | 7.76% | 7.62% | 5.84% | 7.32% | 7.48% | 6.57% | Upgrade
|
| Profit Margin | 4.67% | 4.49% | 3.45% | 4.75% | 4.87% | 4.72% | Upgrade
|
| Free Cash Flow Margin | 14.67% | 17.69% | 6.15% | 5.61% | 12.81% | 1.55% | Upgrade
|
| EBITDA | 2,100 | 2,385 | 3,131 | 3,244 | 1,808 | 1,306 | Upgrade
|
| EBITDA Margin | 7.63% | 8.67% | 11.82% | 13.22% | 8.51% | 7.79% | Upgrade
|
| D&A For EBITDA | -34.14 | 289.4 | 1,584 | 1,448 | 218.06 | 204.62 | Upgrade
|
| EBIT | 2,134 | 2,095 | 1,547 | 1,796 | 1,590 | 1,101 | Upgrade
|
| EBIT Margin | 7.76% | 7.62% | 5.84% | 7.32% | 7.48% | 6.57% | Upgrade
|
| Effective Tax Rate | 26.34% | 26.52% | 26.85% | 24.40% | 23.72% | 22.94% | Upgrade
|
| Revenue as Reported | - | - | 26,497 | 24,531 | 21,248 | 16,759 | Upgrade
|
| Advertising Expenses | - | - | 25.49 | 30.81 | 26.27 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.